Company Filing History:
2 out of 10 
2 out of 11 
1 out of 1 Years Active: 2012-2023
Title: Scott Peterson: Innovator in Pharmaceutical Compounds
Introduction
Scott Peterson is a notable inventor based in Woodinville, WA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific kinases. With a total of 5 patents to his name, Peterson's work has the potential to impact therapeutic applications significantly.
Latest Patents
Among his latest patents, Peterson has developed pharmaceutical compounds that inhibit or modulate the activity of Chk-1 kinase. These inventions not only include the compounds themselves but also encompass pharmaceutical compositions containing these compounds and their therapeutic uses. This innovative approach could lead to advancements in cancer treatment and other medical applications.
Career Highlights
Throughout his career, Scott Peterson has worked with several prominent companies in the pharmaceutical industry. Notably, he has been associated with Oncothyreon Inc. and Sentinel Oncology Limited. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.
Collaborations
Some of his notable coworkers include Robert George Boyle and David Winter Walker. Their collaborative efforts have contributed to the advancement of research and development in the pharmaceutical sector.
Conclusion
Scott Peterson's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His work in developing compounds that target Chk-1 kinase showcases the potential for significant therapeutic advancements.